ArticleNPJ breast cancer2026
CRISPR screens identify PRMT7 as a therapeutic target to enhance T cell-mediated killing in breast cancer.
Wei Shi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it